4L aloi P, Munro CL, Jones KR, et al.Immunologic characteristics of a streptococcus mutans glucosyl- transferase B sucrose-binding site peptidecholera toxin B-subunit chimeric protein. Infect Immun,1996, 64( 12): 28 - 36.
5Bigelis R. Industrial products of biotechnol ogy: application of gene technology. Biotechnology, 1989, 2(7): 667- 676.
6Ales Prokop. Recombinant DNA technology and application. New York, McGnaw-Hill, 1991, 19(4): 483 - 486.
7Champtiaux N, Changeux JP. Knock-out and knock-in mice to investigate the rule of nicotinic receptors in the central nervous system. Curr Drug Target CNS Neurol Disord, 2002,1 (6): 319 - 330.
8Reuter H, Henderson SA, Han T, et al.Cardiac excitation-contraction coupling in the absence of Na( ^+ ) -Ca (^2+ )exchange. Cell Calcium, 2003, 34( 11 ):19 - 26.
9Balakrishnan V, Becker M, Lohrke S, et al. Expression and function of chloride transporters during development of inhibitoryin the auditory brainstem. J Neurosci, 2003, 23(12):4134 -4145.
10Chaperon F, Tricklebank MD, Unger L, et al. Evidence for regulation of body temperature in rats by dopamine D(2)receptor and possible influence of D(1)but not D(3) and D(4) receptors.Neuropharmacology, 2003, 44(8): 1047-1053.
